ATOS
ATOSSA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.56
−12.03%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.86
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.95
- EPS estimate
- -$1.02
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +0.6%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$1.02 | -$0.95 | Beat 6.86% | — |
| May 8, 2026 | -$1.22 | -$1.11 | Beat 9.02% | — |
| Mar 24, 2026 | -$1.05 | -$1.19 | Miss -13.33% | — |
| Nov 12, 2025 | -$1.05 | -$1.05 | In line | — |
| Mar 25, 2025 | -$0.06 | -$0.05 | Beat 16.67% | — |
| Apr 1, 2024 | -$0.05 | -$0.06 | Miss -20.00% | $18.0K |
| Nov 13, 2023 | -$0.07 | -$0.05 | Beat 28.57% | — |
| Aug 14, 2023 | -$0.06 | -$0.06 | In line | — |
| May 15, 2023 | -$0.06 | -$0.05 | Beat 16.67% | — |
| Mar 22, 2023 | -$0.06 | -$0.06 | In line | — |
| Feb 28, 2022 | -$0.04 | -$0.04 | Miss -11.11% | — |
| Nov 15, 2021 | -$0.04 | -$0.04 | Miss -11.11% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026